CEBPB Cancer Research Results

CEBPB, CCAAT/enhancer‐binding protein beta: Click to Expand ⟱

Source:

Type:

CCAAT/enhancer‐binding protein beta (CEBPB)
CEBPB is a transcription factor that regulates genes involved in proliferation, differentiation, immune responses, and inflammation.

– In some contexts, high expression of CEBPB correlates with aggressive tumor behavior and poor clinical outcomes, whereas in other settings it might indicate a more differentiated state and, consequently, a less aggressive phenotype.
- CEBPB expression was obviously elevated in CRC patients, and was associated with poor survival.

Scientific Papers found: Click to Expand⟱

2178-

itraC,

Itraconazole inhibits tumor growth via CEBPB-mediated glycolysis in colorectal cancer

in-vivo,

CRC,

HCT116

xenograft model in tumor-bearing mice

TumCG↓, Glycolysis↓, CEBPB?, ENO1↓, LDHA↓, PKM2↓, GAPDH↓, ECAR↓, OCR↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Mitochondria & Bioenergetics ⓘ

OCR↓, 1,

Core Metabolism/Glycolysis ⓘ

ECAR↓, 1, ENO1↓, 1, GAPDH↓, 1, Glycolysis↓, 1, LDHA↓, 1, PKM2↓, 1,

Proliferation, Differentiation & Cell State ⓘ

CEBPB?, 1, TumCG↓, 1,
Total Targets: 9

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: CEBPB, CCAAT/enhancer‐binding protein beta

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells